Browsing by Author Frydenberg, M

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2002Induction of Apoptosis in low to moderate grade human prostate Carcinoma by red clover derived dietary isoflavonesHusband, Alan; Clare, A; Dowling, C; Frydenberg, M; Jarred, R; Keikha,, M; McPherson, S; Pedersen, John; Risbridger, G; Vet Anatomy and PathologyInduction of Apoptosis in low to moderate grade human prostate Carcinoma by red clover derived dietary isoflavones, Cancer Epidemiology, Biomarkers & Prevention, vol.11, N/A,pp 1689-1696
2017New Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implicationsO'Connell, Dianne; Smith, David; Chambers, S; Dunn, Jeff; Egger, Sam; Frydenberg, M; Hughes, Suzanne; Hyde, Melissa Karen; Stein, Kevin; Wittert, Gary; Yuill, S; School of Public Health: Medicine; School of Public Health: Public HealthNew Challenges in Psycho-Oncology Research III: A systematic review of psychological interventions for prostate cancer survivors and their partners: clinical and research implications, Psycho-Oncology, vol.26, 7, 2017,pp 873-913
2016Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trialKing, Madeleine; Stockler, Martin; Woo, Henry; Bassett, Julie; Bowe, Steven; D'Este, Catherine; Duchesne, Gillian; et al, .; Frydenberg, M; Ledwich, Leo; Loblaw, Andrew; Malone, Shawn; Millar, Jeremy; Milne, Roger; Psychology; NH&MRC Clinical Trials Centre; SAHCS: SurgeryTiming of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial, Lancet Oncology, vol.17, 6, 2016,pp 727-737